Medicure, Inc. (NASDAQ:MCUJF)

PRESS RELEASE

published on 06/24/2024 at 23:00, 1 year 7 months ago

Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property
Medicure Inc. announces asset purchase agreement with CanAm Bioresearch for acquisition of patent and intellectual property related to new chemical entities for therapeutic use

Medicure Inc. Asset Purchase Agreement CanAm Bioresearch New Chemical Entities Therapeutic Use
BRIEF

published on 05/28/2024 at 23:05, 1 year 8 months ago

Medicure Reports Financial Results for Q1 2024 and Director Election Results

Financial Results Director Election Q1 2024 Medicure
BRIEF

published on 05/28/2024 at 23:05, 1 year 8 months ago

Medicure publie ses résultats financiers pour le premier trimestre 2024 et les résultats de l'élection des administrateurs

Résultats Financiers Médicament T1 2024 Élection Du Directeur
PRESS RELEASE

published on 05/28/2024 at 23:00, 1 year 8 months ago

Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results
Medicure Inc. reports Q1 2024 financial results and director elections. Total revenue slightly up, AGGRASTAT® revenue down. Adjusted EBITDA decreased. New director appointed

Revenue Medicure Inc. Director Elections Q1 2024 Financial Results AGGRASTAT®
BRIEF

published on 04/23/2024 at 23:05, 1 year 9 months ago

Medicure reçoit la désignation Fast Track de la FDA pour le traitement MC-1 du déficit en PNPO

Medicure Inc. Désignation De Médicament Orphelin Désignation Fast Track De La FDA MC-1 Carence En PNPO
BRIEF

published on 04/23/2024 at 23:05, 1 year 9 months ago

Medicure Receives FDA Fast Track Designation for MC-1 Treatment for PNPO Deficiency

Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency
PRESS RELEASE

published on 04/23/2024 at 23:00, 1 year 9 months ago

Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
Medicure Inc. receives FDA Fast Track designation for MC-1 to treat PNPO deficiency seizures, a serious condition. Rare Pediatric Disease and Orphan Drug designations granted

Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency Seizures
BRIEF

published on 04/08/2024 at 23:05, 1 year 10 months ago

Medicure Inc. réfléchit à son exercice 2023 et à ses performances au quatrième trimestre

Résultats Financiers Médicament Industrie Pharmaceutique AGGRASTAT ZYPITAMAG
BRIEF

published on 04/08/2024 at 23:05, 1 year 10 months ago

Medicure Inc. Reflects on its 2023 Financial Year and Q4 Performance

Financial Results Pharmaceutical Industry Medicure AGGRASTAT ZYPITAMAG
PRESS RELEASE

published on 04/08/2024 at 23:00, 1 year 10 months ago

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023
Medicure Inc. reports results from operations for the quarter and year ended December 31, 2023. Net revenue, EBITDA, and financial highlights disclosed

Financial Results EBITDA Quarterly Report Medicure Inc. Revenue Analysis

Published on 02/20/2026 at 23:15, 17 minutes ago

DigiPower X Announces Closing of Settlement
Published on 02/20/2026 at 23:00, 32 minutes ago

Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 1 hour 15 minutes ago

Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/20/2026 at 21:40, 1 hour 52 minutes ago

IBC Advanced Alloys Announces Closing of Initial US$1,250,000 Funding by The Lind Partners
Published on 02/20/2026 at 20:15, 3 hours 17 minutes ago

Lithium South Announces Results of its Annual and Special Meeting of Securityholders

View all ACCESSWIRE

Published on 02/20/2026 at 18:36, 4 hours 56 minutes ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 5 hours 1 minute ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:23, 5 hours 9 minutes ago

POS-Transaction in Own Shares
Published on 02/20/2026 at 18:00, 5 hours 32 minutes ago

Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 5 hours 32 minutes ago

Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

View all EQS

Published on 02/20/2026 at 19:29, 4 hours 3 minutes ago

SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 4 hours 3 minutes ago

SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 5 hours 32 minutes ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 5 hours 32 minutes ago

TERACT - Résiliation du contrat de liquidité
Published on 02/20/2026 at 17:35, 5 hours 57 minutes ago

CHIFFRE D'AFFAIRES 2025

View all LES ECHOS COMFI WIRE

News